Label: CELLADIX C.E.F ADVANCED BRIGHTENING AMPOULE- ascorbic acid liquid

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated July 24, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredients

    Ascorbic Acid

  • Purposes

    Skin Brightening

  • Uses

    Helps to brighten facial skin tone.

  • Warnings

    Do not use it on open wounds and sensitive skin.

  • Warnings

    Keep out of reach of children

  • Warnings

    When using this product keep out of eyes. Rinse with water to remove

  • Directions

    After cleansing or toning, take an appropriate amount of the ampoule and gently spread it over the face for absorption.

  • Inactive Ingredients

  • Warnings

    For external use only

  • Warnings

    Stop use and ask a doctor if there are any abnormal symptoms or side effets such as red spots, swelling or itching during or immediately after use.

  • Label

    label

    celladix ampoule

  • INGREDIENTS AND APPEARANCE
    CELLADIX C.E.F ADVANCED BRIGHTENING AMPOULE 
    ascorbic acid liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:83490-605
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ASCORBIC ACID15 g  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    OCTYLDODECETH-16 (UNII: RJV574G0DE)  
    BETASIZOFIRAN (UNII: 2X51AD1X3T)  
    PELARGONIUM GRAVEOLENS FLOWER OIL (UNII: 3K0J1S7QGC)  
    OCIMUM BASILICUM WHOLE (UNII: P4815JL4O3)  
    TRIBUTYL CITRATE (UNII: 827D5B1B6S)  
    HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
    CYSTOSEIRA TAMARISCIFOLIA (UNII: HRU0KH4VFH)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    ACACIA (UNII: 5C5403N26O)  
    LINALOOL, (+/-)- (UNII: D81QY6I88E)  
    OLIVE OIL (UNII: 6UYK2W1W1E)  
    EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)  
    SCUTELLARIA BAICALENSIS ROOT (UNII: 7J95K7ID2S)  
    PANTHENOL (UNII: WV9CM0O67Z)  
    1,2-HEXANEDIOL (UNII: TR046Y3K1G)  
    ARBUTIN (UNII: C5INA23HXF)  
    .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
    3-O-ETHYL ASCORBIC ACID (UNII: 6MW60CB71P)  
    ANHYDROUS TRISODIUM CITRATE (UNII: RS7A450LGA)  
    POVIDONE (UNII: FZ989GH94E)  
    GLUTATHIONE (UNII: GAN16C9B8O)  
    PENTYLENE GLYCOL (UNII: 50C1307PZG)  
    NIACINAMIDE (UNII: 25X51I8RD4)  
    PROPANEDIOL (UNII: 5965N8W85T)  
    WATER (UNII: 059QF0KO0R)  
    BETAINE (UNII: 3SCV180C9W)  
    GREEN TEA LEAF (UNII: W2ZU1RY8B0)  
    SUCROSE (UNII: C151H8M554)  
    LIMONENE, (+/-)- (UNII: 9MC3I34447)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    HYDROGENATED SOYBEAN LECITHIN (UNII: H1109Z9J4N)  
    CAPRYLIC/CAPRIC/LAURIC TRIGLYCERIDE (UNII: FJ1H6M2JG9)  
    FURTERENE (UNII: TY1X1WG26A)  
    ASTAXANTHIN (UNII: 8XPW32PR7I)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    ORANGE PEEL (UNII: TI9T76XD44)  
    UBIDECARENONE (UNII: EJ27X76M46)  
    BUTETH-3 (UNII: OC116GRO69)  
    CHAMAECYPARIS OBTUSA LEAF (UNII: 7OL154J5XB)  
    MORUS ALBA BARK (UNII: 7O71A48NDP)  
    SODIUM ASCORBATE (UNII: S033EH8359)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    BETA CAROTENE (UNII: 01YAE03M7J)  
    ADENOSINE (UNII: K72T3FS567)  
    .BETA.-GLUCOGALLIN (UNII: 4X7JGS9BFY)  
    POLYGLYCERYL-3 DISTEARATE (UNII: ZI1LK470XV)  
    VINCETOXICUM ATRATUM WHOLE (UNII: U3176B0S5J)  
    SODIUM BENZOTRIAZOLYL BUTYLPHENOL SULFONATE (UNII: 0LA2QC9O3Z)  
    LAVANDULA ANGUSTIFOLIA WHOLE (UNII: 51217XIL5L)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:83490-605-0115 mL in 1 AMPULE; Type 0: Not a Combination Product07/24/2023
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other07/24/2023
    Labeler - 2359 US INC (118974080)
    Registrant - 2359 US INC (118974080)
    Establishment
    NameAddressID/FEIBusiness Operations
    Isamogu Inc.695695834manufacture(83490-605)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!